Summary. The in vivo radioautographic method has been applied to elucidate the mechanism of direct peptide hormone "feedback" action in the CNS. Using this method we have identified the circumventricular organs of the brain as general endocrine target tissues for a variety of blood-borne polypeptide hormones, including insulin. In the arcuatemedian eminence region of the hypothalamus bloodborne insulin directly interacts with receptive nerve terminals, suggesting that insulin acts to influence the electrical activity of select hypothalamic nerve circuits at the level of synaptic transmission. Recent results obtained from preliminary surgical and chemical lesion studies of brain indicate that insulin-receptive nerve terminals in the arcuate-median eminence region arise from neurons intrinsic to the medial basal hypothalamus. This has lead us to propose the concept of the hypothalamic tuberoinfundibular insulin-receptive neuron and its axon collaterals as a pathway for the centripetal flow of insulin "signals" in the form of electrical impulses. We envisige that the neuroanatomic pathway, provided by the hypothalamic tuberoinfundibular neuron, functions to link changes in body metabolic activity, as reflected in changing levels of circulating insulin, to the neuronal process of elaborating specific central metabolic-regulatory programs. This pathway could be of key importance in understanding and combating metabolic disease.
Summary.
The in vivo radioautographic method has been applied to elucidate the mechanism of direct peptide hormone "feedback" action in the CNS. Using this method we have identified the circumventricular organs of the brain as general endocrine target tissues for a variety of blood-borne polypeptide hormones, including insulin. In the arcuatemedian eminence region of the hypothalamus bloodborne insulin directly interacts with receptive nerve terminals, suggesting that insulin acts to influence the electrical activity of select hypothalamic nerve circuits at the level of synaptic transmission. Recent results obtained from preliminary surgical and chemical lesion studies of brain indicate that insulin-receptive nerve terminals in the arcuate-median eminence region arise from neurons intrinsic to the medial basal hypothalamus. This has lead us to propose the concept of the hypothalamic tuberoinfundibular insulin-receptive neuron and its axon collaterals as a pathway for the centripetal flow of insulin "signals" in the form of electrical impulses. We envisige that the neuroanatomic pathway, provided by the hypothalamic tuberoinfundibular neuron, functions to link changes in body metabolic activity, as reflected in changing levels of circulating insulin, to the neuronal process of elaborating specific central metabolic-regulatory programs. This pathway could be of key importance in understanding and combating metabolic disease.
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The central nervous system (CNS) organizes patterns of behavior and glandular secretion, and a myriad of autonomic functions into coordinated, integrated programs designed in large measure to satisfy everchanging body nutritional requirements, promote growth and maintain metabolic balance [26-28, 43, 47, 71] . To act appropriately the CNS must have some way of measuring or "sensing" the status of critical body metabolic processes. However, the source or carrier of this information has not been identified. Since specific metabolic events often precipitate the expression of discrete central rnetabolicregulatory functions, it has been theorized that blood-borne "feedback cues" arise from body metabolic activity to activate the CNS appropriately [19, 22, 26, 27, 33, 67, 69] . Polypeptide hormones may act as these cues, since they are intimately involved in tissue metabolic regulation, and their circulating levels often closely reflect different body metabolic states [69] . Furthermore, certain bloodborne polypeptide hormones, such as insulin [9, 11, 34, 54-56, 70, 72] , angiotensin II [46] and prolactin [17] , have been shown to exert direct effects on specific central regulatory functions. Consequently, it may well be that in addition to their traditional roles in tissue metabolism, blood-borne peptide hormones act as "messengers" alerting the brain to changes in the internal milieu by stimulating specific central regulatory responses.
In order to evaluate the role of insulin or other blood-borne polypeptide hormones as "messengers" linking central metabolic regulatory functions to body metabolic needs, it is critical to determine (a) whether blood-borne polypeptide hormones can interact with the CNS, (b) where the interaction occurs, (c) what neuronal systems are activated by the interaction, (d) how the interaction is translated into a cogent message intelligible to the CNS, (e) how this message is disseminated to the appropriate regulatory "effector" sites in the brain, (f) what central regulatory systems are involved, and (g) what effect does alteration in body metabolism have on hormone-to-brain communication.
In Vivo Radioautographic Method for Identifying Receptors for Insulin and Other Blood-Borne Polypeptide Hormones in the CNS
If a polypeptide hormone acts directly upon central neuronal elements, then such elements must, in accordance with the present view of hormone action [25] , possess receptors for the hormone. We have used a procedure involving the in vivo administration of 125I-labelled hormones to identify central binding sites for insulin and other polypeptide hormones. Shortly after systemic injection of labelled hormone, perfusion with Ringer lactate solution is begun via an intracardiac cannula, to wash from the vasculature and interstitial fluid unbound radioactivity. This is followed by perfusion with a fixative solution to retain receptor-bound radioactivity for radioautographic visualization and quantitative analysis. Since the intensity of radioautographic reactions reflects the amount of bound radioactivity [23] , the difference in reaction intensities obtained following the injection of 12sI-insulin alone and that obtained following the injection of 125I-insulin with excess unlabelled insulin provides, by analogy with the in vitro determination of specific binding [3] , an in vivo measurement of specific binding. Using this approach we have localized specific binding sites for bloodborne insulin to two different cellular compartments of the CNS: (a) an endothelial microvessel compartment which is distributed throughout the CNS; and (b) a neuronal compartment which is localized exclusively to the circumventricular organs of the brain.
Insulin Binds to Brain Blood Vessels in Vivo
Using the in vivo radioautographic approach we have shown that blood vessels throughout the CNS bind blood-borne insulin rapidly and with considerable specificity [59] . The binding of insulin to cerebral microvessels was inhibited by progressively increasing concentrations of coinjected unlabelled insulin, but was unaffected by structurally dissimilar polypeptides. Microvessel binding could explain, at least in part, the presence of insulin receptors in homogenates [21] and subcellular fragments [39] from many different parts of the brain. At the electron microscopic level microvessel endothelium appears to be the cellular site of the insulin receptors (Fig. 1) . This has been confirmed using classical in vitro competitive analyses of highly purified microvessels isolated from bovine brain (Drs I. Gozes and M. Moskowitz, Laboratory of Neuroendocrine Regulation, Massachusetts Institute of Technology, personal communication).
Direct insulin binding to brain endothelium in vivo is surprising with respect to the traditional view that insulin does not alter directly rates of glucose transport across the blood-brain barrier [31] . However, its importance to human neurophysiology is emphasized by our observation of insulin-specific binding in vivo to microvessels of the primate brain (van Houten, B. Landau, B.I. Posner, unpublished observations). It is possible that insulin plays a role in regulating amino acid transport across the bloodbrain barrier [73] , or brain electrolyte balance [2] , or that insulin exerts a generalized effect on brain activity by a direct action on another aspect of bloodbrain barrier function perhaps unrelated to glucose uptake. An important corollary to our studies is that the blood-brain barrier physically prohibits direct interaction of blood-borne insulin with neurons in almost all regions of the CNS.
Neuronal Basis of Direct Insulin-Specific Action on the CNS

Hormone-receptive Role of the Circumventricular Organs
Within 5 min of systemic injection insulin penetrates into the circumventricular organs of the brain [60], as these regions do not possess a prohibitive bloodbrain barrier [66] . However, in these regions the binding of 125I-insulin was strikingly reduced by coinjected unlabelled insulin (Fig. 2) . Detailed study of the median eminence showed that the binding of J2sI-insulin was blocked by coinjected unlabelled insulin, insulin analogues and structurally dissimilar polypeptide hormones in parallel with their ability to inhibit insulin binding to its receptor in vitro (Fig. 3) . Similar observations were obtained in the adjacent hypothalamic arcuate nucleus [60] and in the area postrema (van Houten and Posner, unpublished). These observations indicate that radioautographically visualized binding sites for insulin in the circumventricular organs have the specificity characteristics of biologically important insulin receptors.
Neural Mechanisms of Insulin Action in the Hypothalamus
Several studies have provided evidence that insulin acts directly on hypothalarnic structures, for example after insulin injection directly into the hypothalamus Fig. 1 . Electron microscope radioautograph from rat neocortex demonstrating the direct binding of blood-borne 125I-insulin to microvessel endothelium. The in vivo radioautographic identification of endothelial insulin receptors may explain in part the widespread distribution of insulin receptors in membrane preparations of brain homogenates [21, 40] [20] and modifies noradrenergic turnover [34] . Since all but the latter effect have been observed following systemic administration of insulin [1, 10, 55] , cellular elements in the basal hypothalamus, subserving specific metabolic regulatory functions, appear to be directly responsive to blood-borne insulin. Radioautographically identified specific binding sites for blood-borne insulin in the medial basal hypothalamus [60] may mediate some or all of the insulin effects on basal hypthalamic functions. Thus, high resolution identification of insulin-receptive elements in the median eminence and arcuate nucleus would possibly elucidate a cellular basis for the mechanism of insulin action in this region. Previously [61] in electron microscope radioautographs from rats injected with ~25I-insulin alone, greater than 80% of all bound radioactivity visualized in the external median eminence was restricted to neuronal processes, primarily to nerve terminals (Fig. 4 a) , but also to pre-terminal axons. Less than one-sixth of the bound radioactivity was localized to glia. In the arcuate nucleus axons and synaptic terminals were most frequently labelled ( Fig. 4b-d ). However, in rats coinjected with unlabelled insulin, bound radioactivity resistant to competitive binding inhibition was restricted to glia. Thus, in both regions of the medial basal hypothalamus unlabelled insulin profoundly reduced 125I-insulin binding to axons and axon terminals, but exerted no obvious blocking effect on 125I-insulin binding to neighbouring glia (Fig. 5) . The selective blockade of neuronal 125I-insulin binding by unlabelled insulin indicates that the specific binding sites for blood-borne insulin in the external median eminence and arcuate nucleus, previously defined by light microscope radioautography, are in fact associated with axons and their terminals.
The specific interaction of insulin with axon terminals in the external median eminence raises the possibility that blood-borne insulin may stimulate directly the release of hypophysiotropic substances. There is evidence that insulin acts via the basal hypothalamus to directly alter hypophysiotropic control of growth hormone secretion [45] . Axonal and synaptic insulin receptors in the arcuate nucleus seem to be ideally situated to influence synaptic transmission, and thereby bias interneuronal communication and the possible regulatory functions arising from such communication. At either location, however, insulin receptors may mediate local effects of insulin on hypothalamic electrical activity [1, 38] , and in concert comprise a hypothalamie network of hormone-responsive nerve circuits which directly transform local insulin-receptor interactions into electrical signals influencing central metabolic regulatory functions.
Evidence for a Hypothalamic Tuberoinfundibular System of Insulin-receptive Neurons
Further elucidation of the neuronal mechanisms of insulin action in the hypothalarnus requires complete definition in neuroanatomic and neurochemieal terms of the neuronal systems with which bloodborne insulin interacts. This involves the identification of the nerve cells which give rise to the nerve terminals bearing insulin receptors in the median eminence and arcuate nucleus. Precise localization of insulin receptive perikarya will provide a structural basis to elucidate the anatomic pathways over which insulin "signals" are conveyed to the appropriate autonomic and behavioral effector sites in the CNS. We have begun this by employing the in vivo radioautographic approach in combination with various surgical and chemical interventions to define this neuronal system. Our first studies involved the use of the "Halasz knife" [18] to surgically deafferent the medial basal hypothalamus unilaterally from parts of the brain at progressively increasing radii from the Fig. 4 . a Electron microscope radioautograph from rat median eminence demonstrating direct binding of blood-borne ~25I-insulin to specific sites associated with free nerve terminals. In the centre of the field is a radiolabelled nerve terminal which is surrounded by unlabelled nerve terminals (NT) and glial processes (G). Pores or fenestrae (f) in the endothelial cells (EN) lining the primary capillary plexus of the median eminence permit the rapid translocation of blood-borne insulin, as well as other polypeptides [62, 63, 65] , to specific nerve terminal binding sites (bold arrow), x 18,000. b and c Electron microscope radioautographs from the rat arcuate nucleus showing the direct binding of blood-borne 125I-insulin to specific binding sites associated with synaptic terminals. Radiolabelled terminals generally exhibit mixed populations of dear and dense-core vesicles. Often the radiolabel appeared to be closely associated with the vesicle population, suggesting that the insulin-receptor complex has been internalized within the terminal, d -dendritic spine, x 24,000. d Electron microscope radioautograph from the rate arcuate nucleus showing close association of 125I-insulin binding sites with vesicle aggregates at the synaptic cleft (SC). Images such as these suggest that insulin acts to alter synaptic transmission possibly via effects on neurotransmitter synthesis or release.
• 24,000 a r c u a t e -m e d i a n e m i n e n c e region. W e r e a s o n e d that since the sweep of the knife will sever and thus d estroy axonal p r o j e c t i o n s to this region on the affected side of the brain [41], but leave axona! p r o j e c t i o n s on the c o n t r a l a t e r a l side intact, knife cuts that p r o d u c e a unilateral deficit in insulin binding capacity in the a r c u a t e -m e d i a n e m i n e n c e region on the affected side will indicate b o t h the p a t h w a y of the i n s u l i n -r e c e ptive axons t o w a r d this region and the distance of the p a r e n t p e r i k a r y a from it. In p r e l i m i n a r y u n p u b l i s h e d studies (van H o u t e n , N a n c e , G a u t h i e r , Posner) we found that unilateral cuts t h r o u g h the mediial foreb r a i n b u n d l e that d e a f f e r e n t the m e d i a l h y p o t h a l amus from the rest of the brain do not r e d u c e the insulin binding capacity of the affected side relative to the c o n t r a l a t e r a l intact side. This o b s e r v a t i o n suggests that insulin-receptive axonal processes in the basal h y p o t h a l a m u s are not e x t r a h y p o t h a l a m i c in origin, but r a t h e r b e l o n g to nerve cells intrinsic to the m e d i a l h y p o t h a l a m u s . Thus insulin-receptive axons . Thus, in the external median eminence of rats injected with 12~I-insulin alone 83% of all silver grains were localized to axonal processes. A 500-fold excess of coinjected unlabelled insulin reduced markedly the total 12~I-insulin binding in this region in light microscope radioautographs. However, electron microscope radioautography showed that 83% of this residual reaction was localized to non-neuronal elements. Unlabelled insulin blocked selectively 12sI-insulin binding to neuronal elements, but had no obvious effect on glial binding regulation of growth hormone secretion and body weight during development. The possibility of a hypothalamic tuberoinfundibular system of insulin-receptive neurons should be considered in light of electrophysiologic evidence that hypothalamic tuberoinfundibular neurons possess multiple axon collaterals which project to numerous sites within the brain, as well as to the median eminence [48, 49] . These studies have shown that impulses initiated by electrical shocks to the median eminence are propagated antidromically to discrete sites in the hypothalamus and more distant regions of the brain, such as the preoptic area and amygdala, via collateral projections of tuberoinfundibular axons. This aspect of tuberoinfundibular physiology could represent the neuroanatomic pathway over which insulin "signals" are disseminated to specific effector sites deep within the brain. Thus, if electrical impulses are generated by direct binding of blood-borne insulin to receptive terminals in the basal hypothalamus, then it is possible that these electrical impulses could travel via collateral projections to activate specific hypothalamic and extrahypothalamic centers (Fig. 6) . By this mechanism the rapid electrical changes in olfactory-related amygdaloid units following systemic administration of insulin [8] may reflect insulin activation of receptive tuberoinfundibular axons with amygdalopetal collaterals. may be hypothalamic tuberoinfundibular projections.
Consistent with this possibility are preliminary results of our in vivo radioautographic evaluation of the insulin-specific binding capacity of the medial basal hypothalamus of adult rats treated neonatally with monosodium glutamate (MSG). In treated rats a large portion of the arcuate neuronal population is destroyed early in its development, and thus the median eminence is deficient in terminals arising from arcuate neurons. Axons projecting to the median eminence from nerve ceils in other regions of the CNS, however, are unaffected [36] . In adult rats treated neonatally with MSG we have found that the insulin-specific binding capacity of the median eminence and residual arcuate nucleus is reduced in half, suggesting that a sizeable percentage of the insulinreceptive axonal elements in this region arise from tuberoinfundibular arcuate neurons. The fact that developing MSG-treated rats become deficient in growth hormone, stunted in growth and obese [36] suggests that insulin-receptive tuberoinfundibular arcuate neurons are critically involved in the central
Does Insulin Act via a GABAergic Mechanism?
Infusion of insulin into the hypothalamus modifies norepinephrine release only after infusion has ceased [34] , suggesting that insulin interacts indirectly with noradrenergic terminals. In our radioautographic studies the inability to hypothalamic deafferentation to reduce the insulin binding capacity of the basal hypothalamus implies that insulin does not directly interact with neurotransmitter systems, such as the brain stem catecholaminergic projection [24] , which originate from cells located outside the hypothalamus. Alternatively, it may be that insulin actions are mediated by a class of neurotransmitter produced locally within the medial hypothalamus. Gamma aminobutyric acid (GABA), an inhibitory neurotransmitter synthesized by hypothalamic neurons [57], is one possible candidate for the following reasons:
(1) The GABA content of the medial basal hypothalamus, unlike that for most hypothalamic neurotransmitters, but like the neuronal insulin binding capacity of this region, is unaffected by hypothalamic deafferentation [41, 57] . Furthermore, the close topographic correspondence of insulin- ). Blood-borne insulin passes from the portal circulation through endothelial fenestrae (Fig. 4 a) and binds to a receptive terminal of the tuberoinfundibular collateral. Electrical impulses generated as a result of direct hormone-receptor interaction at the level of the tuberoinfundibular collateral [1] are relayed by intrahypothalamic [2] and extrahypothalamic [3] collaterals to sites behind the blood-brain barrier, where the insulin "signals" participate in the reprogramming of central metabolic-regulatory activities. Via this pathway changes in body metabolic activity, as reflected in changing levels of circulating insulin, could be linked to the neuronal process of determining central metabolic-regulatory responses. Hypothalamic insulin-receptive neurons may also be situated to interact with insulin delivered by diffusion from the cerebrospinal fluid ([4] CSF) [9, 70, 72] . A similar pathway may exist to mediate the effects of other blood-borne polypeptide hormones on receptive terminals in the median eminence [62, 63, 65] . Indeed, hormone-receptive nerve terminals in the median eminencearcuate region may function to concentrate and internalize blood-borne polypeptide hormones so that they can be distributed via axonal transport through collateral branches of the tuberoinfundibular axon to specific sites of action behind the blood-brain barrier specific binding sites in the rat median eminence and sites of specific GABA uptake in vivo [58] provide a topographic basis for a possible direct action of blood-borne insulin on GABA-ergic terminals.
(2) Blood-borne insulin may directly influence GABA metabolism in the medial basal hypothalamus. In support of this are studies showing that:
(a) levels of GABA in the hypothalamus covary with plasma levels of glucose [30] ; (b) 14C-glucose is preferentially metabolized to 14C-GABA in the medial basal hypothalamus [35] ; and (c) blood-borne insulin seems to enhance directly the uptake and metabolism of blood-borne glucose by the medial basal hypothalamus [10, 42] , possibly via aerobic pathways [44] .
(3) Both insulin [38] and GABA [74] inhibit the electrical activity of medial hypothalamic neurons. Furthermore ventromedial hypothalamic glucoreceptive neurons (known to be insulin-sensitive [38]) exhibit post-excitatory depression during the continuous infusion of glucose [32] . Likewise, certain hypothalamic tuberoinfundibnlar neurons exhibit a post-excitatory depression possibly mediated by a recurrent inhibitory collateral, which can be partially blocked, by picrotoxin, a GABA antagonist [74] .
Thus, it seems plausible to speculate that bloodborne insulin directly activates a hypothalamic network of GABA-ergic nerve terminals, which are functionally linked to the local availability of metabolizable glucose as a substrate precursor for neurotransmitter synthesis and release.
Neural Basis of Insulin-specific Action in the Area Postrema
Light microscope radioautographic studies similar to the studies performed on the median eminence (Fig. 3) [65] . These topographic differences in the distribution of hormone-specific binding sites suggest that each peptide hormone interacts with a select class of tuberoinfundibular terminal. This cellular specificity may represent the structural basis for direct peptide hormone effects on discrete central regulatory functions unpublished observations). Unlike the median eminence, however, the area postrema contains nerve cell bodies as well as axonal processes [66] . In electron microscope radioautographs of rats injected with 125I-insulin alone the majority of silver grains were localized to nerve cells, principally dendrites [64] . Two-thirds of all dendrite-associated grains occurred over pockets of cytoplasm containing collections of smooth saccular cisternae, vesicles and multivesicular bodies. Grains within neuronal cell bodies were similarly localized to vacuolar elements associated with the Golgi apparatus. In rats coinjeeted with unlabelled insulin the density of grains over the area postreama was greatly reduced. These residual grains, representing bound radioactivity not competitively blocked by coinjected unlabelled insulin, were located predominately (75-80%) with glia. However, grains over Golgi-associated structures in neuronal perikarya were rare, and dendritic binding was greatly reduced. These results indicate that insulin receptors in the rat area postrema are associated with neurons, and suggest that the hormone-receptor complex, once formed, is rapidly internalized within Golgi-related vacuolar elements of neuronal dendrites and cell bodies. Specific uptake of 125I-insulin and concentration within nerve cell bodies of the area postrema has been confirmed in light microscope radioautographic studies of rat area postrema following intracerebrospinal fluid injection of 125I-insulin alone of along with unlabelled insulin (van Houten, Baskin, West, Woods, Posner and Porte, unpublished). Insulin-concentrating neurons, located primarily along the lateral border of the area postrema with the medial solitary nucleus, were observed to retain the radiolabel for at least as long as 48 h after injection (longer periods were not studied). Thus, unlike insulin receptors in the medial basal hypothalamus, which are associated principally with axonal elements, insulin receptors in the area postrema are associated principally with dendrites, and are rapidly internalized and transported to the parent cell body. These regional differences in the cellular site of insulin binding and subsequent handling by neuronal elements suggest possible regional differences in insulin action.
Neuroanatomical considerations raise the possibility that insulin-receptive nerve terminals in the basal hypothalamus arise from the insulin-concentrating neurons of the area postrema. Studies utilizing axonal anterograde-retrograde transport techniques [6, 50] and lesion-degeneration techniques [40] confirm axonal projections from the medial solitary nucleus to the basal hypothalamus. Since certain of the rostrally-projecting axonal systems of the medial solitary nucleus pass through the periventricular brain stem and diencephalon [50] , rather than through the medial forebrain bundle, they may not have been eliminated in our initial hypothalamic deafferentation studies. However, published accounts illustrating the location of these neurons [6, 50] do not suggest a close topographic correspondence with insulin-concentrating neurons along the lateral area postrema. The projection field of insulinconcentrating neurons likely involves the adjacent vagal nuclei which are reciprocally connected with the area postrema (50 for review). Thus, these receptive neurons may a role in relaying insulin "messages" ~to this major parasympathetic center. 
Significance
The Circumventricular Organs as General Endocrine Target Tissues
The circumventricular organs, as they are the only regions of the CNS deficient in a prohibitive bloodbrain barrier [66] , are therefore the only regions of the CNS where blood-borne polypeptide hormones can interact physically with central neurons. In recently expanding the scope of our studies we have found that the circumventricular organs possess specific binding sites for a variety of blood-borne polypeptide hormones in addition to insulin [62, 63, 65] . In each instance the blood-borne polypeptide hormone interacts with specific binding sites which are concentrated in discrete subregions of the circumventricular organs (Fig. 7) . These additional hormone studies, which further substantiate the validity of the in vivo radioautographic method for identifying hormone-specific binding sites, reveal that the circumventricular organs of the CNS are in fact a new class of general endocrine target tissue. Moreover, our in vivo radioautographic studies with insulin and other blood-borne polypeptide hormones ~:epresent the first direct demonstrations of the unique and fundamental importance of the circumventricular organs in hormone-to-brain communication.
Insulin "Feedback" on the CNS in Healthy
Topographically, the circumventricular organs are situated immediately adjacent to and are neuroanatomically linked with important behavioral and autonomic centers, such as the vagal nuclei, involved in secretomotor regulation [29, 68] and taste, perception [50] , and the medial basal hypotlhalamus, involved in hypophysiotropic regulation [118] and ingestive behavior [7] . Thus, the intimate neuroanatomical relationship of the circumventricnlar organs to vital homeostatic centers and the presence of insulin receptors in these regions suggests that circumventricular insulin receptors function to link changes in circulating insulin to the process of elaborating central metabolic-regulatory programs (Fig. 8) . For example, rising levels of circulating insulin associated with feeding may act via receptors in the area postrema to stimulate vagal-mediated gas- In recent studies, we performed a unilateral hypothalamic deafferentations using the Halasz knifecut method. Two weeks later, we performed our routine radioautographic experiments reasoning that if the median eminence on the lesioned side is shows reduced binding relative to the control lateral side, we can conclude that some portion of the insulin receptive axons in the median eminence enter through the region of the hypothalamus traversed by the knife cut unimportant. We found that unilateral cuts passing just lateral to the fornix or between the fornix and the ventromedial nucleus did not reduce binding capacity of the median eminence. On the other hand, small electrolytic lesions placed in the center of the arcuate nucleus on one side resulted in a marked reduction of insulin binding capacity of the ipsilateral median eminence. These studies combined implicate the medial basal hypothalamus as the likely site of origin for insulin-receptive nerve terminals in the median eminence. This is consistent with our analysis of the insulin binding capacity of the median eminence from adult rats treated neonatally below with monosodium glutamate. With this technique, as many as 80 or 90% of arcuate neurons die early in development. The animals become obese and have reduced growth hormone levels. The median eminence area of these rats showed reduced insulin-specific binding.
Fernstrom: Have you done any kind of control to make sure you're not simply damaging the blood supply to the median eminence?
van Houten: The blood supply of the median eminence comes directly from the portal circulation, not the hypothalamus. Our lesions have no effect on this supply and should not compromise it. Further, by using the contralateral side as a control, we have seen no evidence of altered blood supply.
Novin: It seems a very strange nervous system which you contemplate. For if, as you suggest, the receptors are indeed on the axon terminals, retrograde axonal transmission must be occurring to get the message to other terminals.
van Houten: I am suggesting two possible mechanisms by which blood-borne insulin could generate an electrical message in the median eminence-arcuate area, and this message could be disseminated to other regions of brain behind the blood-brain barrier. First, insulin could depolarize receptive nerve terminals occurring in synaptic contact with another neuron. Depolarization resulting in the release of a neurotransmitter could alter the electrical activity of the post-synaptie neuron and its axonal projections. Secondly, insulin could depolarize non-synaptic receptive nerve terminals occurring as free nerve endings in the median eminence. Depolarization could produce an electrical signal which is then propagated antidromically into the brain by retrograde transmission along the parent axon and its collateral projections.
Novin: Is there a precedent for the type of neuron you suggest?
van Houten." Yes, eiectricophysiological studies demonstrate that electrical shocks are applied to the median eminence, the same signal appears rapidly in both the medical basal hypothalamus and other areas of brain behind the blood-brain burrier, such as the amygdala. Other studies have shown that insulin causes changes of electrical activity within the amygdala within minutes following systemic administration. The rapid time course of these amygdaloid responses to blood-borne insulin could reflect rapid retrograde conduction of impulses generated at receptive terminals in the median eminence and conveyed along axon collaterals to the amygdala. There may be, of course, synaptic interruptions in such a pathway; we are simply postulating a more direct and rapid route.
